CICigna

$280.86

The financials

Cigna by the numbers

Cigna (CI) reported revenue of $71.7B in Q2 2026 (quarter ended June 30, 2026), up 6.7% from the same quarter a year earlier. That came with a gross margin of 21% and net income of $1.88B (2.6% of revenue). For the full year FY2025, revenue was $274.9B (+11% year on year) and net income $6.29B. Its largest product in 2026-Q1 was Network Pharmacy at $31.1B, 49% of the disclosed total, just ahead of Home Delivery And Specialty at 31%.

Cigna income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$71.7B$67.2B+6.7%
Gross profit$15.0B$13.9B+7.6%
Operating income$2.68B$2.31B+16%
Net income$1.88B$1.63B+15%
Diluted EPS$6.29$5.71+10%
Revenue by product, 2026-Q1, as reported to the SEC
ProductRevenueShare
Network Pharmacy$31.1B49%
Home Delivery And Specialty$19.8B31%
Service$4.44B7.1%
Service Fees And Other$4.12B6.5%
Other Pharmacy$3.43B5.4%
Service Other$159M0.3%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q1 2026Total $63.02B (-3.1%)
Service Fees And Other grew +20% year on yearService Other -1.9% year on year
  • Network Pharmacy$31.08BQoQ -4.4%year on year +10%
  • Home Delivery And Specialty$19.79BQoQ -3.5%year on year +4.5%
  • Service$4.44BQoQ +1.4%year on year +14%
  • Service Fees And Other$4.12BQoQ +5.2%year on year +20%
  • Other Pharmacy$3.43BQoQ +0.68%year on year +11%
  • Service Other$159.0MQoQ -42%year on year -1.9%
Segment sum = 92% of reported consolidated revenue · Latest source: 10-Q filed 2026-04-30, SEC EDGAR